Literature DB >> 2968403

The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction.

M R Shalaby1, T Espevik, G C Rice, A J Ammann, I S Figari, G E Ranges, M A Palladino.   

Abstract

The influence of recombinant human TNF-alpha and -beta (rHuTNF-alpha and -beta) in a human mixed lymphocyte reaction (MLR) was investigated. The addition of 1000 U/ml of either cytokine at the initiation of culture caused up to a sixfold increase in [3H]thymidine incorporation by responder cells. Furthermore, it was found that endogenous HuTNF-alpha is produced after allogeneic cell interaction and can be detected in the MLR supernatant within 1 h of culture initiation. The results also show that, in the absence of exogenous HuTNF-alpha, antibodies to rHuTNF-alpha can cause a significant inhibition of the MLR. These observations indicate the importance of TNF-alpha in allogeneic cell interaction and raise considerations for the use of antibodies, or other antagonists, to TNF-alpha as regulators of disease states associated with cell-mediated immune reactions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968403

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin.

Authors:  P F Piguet
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Constitutive synthesis of tumor necrosis factor in the thymus.

Authors:  B P Giroir; T Brown; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 3.  Tumor necrosis factor and immunopathology.

Authors:  P F Piguet; G E Grau; P Vassalli
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell lines.

Authors:  S S Sung; L K Jung; J A Walters; E W Jeffes; G A Granger; S M Fu
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.

Authors:  R de Jong; P Stokkers; E Lamme; J M Kool; F Borst; M Brouwer; F Miedema; R A van Lier
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

6.  T-cell activation and differentiation are regulated by TNF during murine DBA/2-->B6D2F1 intestinal graft-versus-host disease.

Authors:  G R Brown; D L Thiele
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

7.  Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study.

Authors:  E Arbustini; M Grasso; M Diegoli; M Bramerio; A S Foglieni; M Albertario; L Martinelli; A Gavazzi; C Goggi; C Campana
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

Review 8.  Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.

Authors:  Ruth Whittington; Diana Faulds
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

9.  The production of chemotactic cytokines in an allogeneic response. The role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3.

Authors:  N W Lukacs; S L Kunkel; M D Burdick; R M Strieter
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

10.  Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.

Authors:  R Karttunen; H M Surcel; G Andersson; H P Ekre; E Herva
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.